Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Paediatrics

Children need optimal management of chronic hepatitis B

Current therapies for chronic HBV infection are focused on adults. However, the timing of primary infection of HBV often occurs during infancy or childhood, particularly in endemic areas. Children have the potential for a long lifespan and should be treated properly and early before complications develop.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sokal, E. M. et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines. J. Hepatol. http://dx.doi.org/10.1016/j.jhep.2013.05.016.

  2. Chen, H. L. et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142, 773–781 (2012).

    Article  PubMed  Google Scholar 

  3. Chang, M. H., Hwang, L. Y., Hsu, H. C., Lee, C. Y. & Beasley, R. P. Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 8, 374–377 (1988).

    Article  CAS  PubMed  Google Scholar 

  4. Chang, M. H. et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 13, 316–320 (1991).

    Article  CAS  PubMed  Google Scholar 

  5. Ni, Y. H. et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 132, 2340–2345 (2007).

    Article  PubMed  Google Scholar 

  6. Lang, T. et al. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J. Hepatol. 55, 762–769 (2011).

    Article  CAS  PubMed  Google Scholar 

  7. Chang, J., Block, T. M. & Guo, J. T. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy. Antiviral Res. 96, 405–413 (2012).

    Article  CAS  PubMed  Google Scholar 

  8. Frodsham, A. J. et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc. Natl Acad. Sci. USA 103, 9148–9153 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wu, J. F. et al. Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men. Gastroenterology 138, 942–948 (2010).

    Article  PubMed  Google Scholar 

  10. Cox, N. & Tillmann, H. Emerging pipeline drugs for hepatitis B infection. Expert Opin. Emerg. Drugs 16, 713–729 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author acknowledges the grant support of the National Health Research Institutes, Taiwan (Grant No. NHRI-EX102-10001BI).

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, MH. Children need optimal management of chronic hepatitis B. Nat Rev Gastroenterol Hepatol 10, 505–506 (2013). https://doi.org/10.1038/nrgastro.2013.137

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2013.137

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing